Branded Rx · FDA-approved

Mounjaro®

FDA-approved tirzepatide. Dual mechanism, branded path.

Mounjaro is the FDA-approved branded version of tirzepatide, manufactured by Eli Lilly and indicated for type 2 diabetes (with weight management as a documented effect). At Cypress, you pay up front and submit to your insurance for reimbursement.

  • FDA-approved — manufactured by Eli Lilly
  • Once-weekly subcutaneous injection
  • Dual GLP-1 / GIP receptor agonist
  • Pay up front, submit to your insurance for reimbursement
  • Clinician oversight and pharmacy coordination included
Start your assessment

Why branded

When the branded path is the right path.

Woman in midlife considering her care options

Branded Mounjaro is FDA-approved, manufactured under the strictest regulatory standards, and the dual GLP-1 / GIP path your insurance plan is most likely to recognize for reimbursement.

If you have insurance coverage that may reimburse for branded GLP-1, your out-of-pocket on Mounjaro can be lower than the cash price suggests. Your clinician will help you think through whether branded Mounjaro, branded Zepbound (the obesity-indicated tirzepatide brand), or compounded options fit your situation best.

Cypress is not affiliated with Eli Lilly. Mounjaro is a registered trademark of its respective owner.

How Cypress branded works

What we do, and what we don't.

1
We prescribe and coordinate
Your clinician evaluates whether branded GLP-1 is appropriate, prescribes it, and coordinates with a pharmacy to fulfill.
2
You pay up front
You pay the full cost at fulfillment. We confirm the price with you before any charge.
3
You file the claim
We provide all documentation. You submit to your plan and they reimburse you directly. We do not bill insurance.

Side effects & safety

What to know before you start.

Woman reviewing health information at home

Most common: nausea, decreased appetite, mild diarrhea, constipation, fatigue.

Less common but important: pancreatitis, gallbladder issues, low blood sugar.

Not appropriate if: personal/family history of medullary thyroid carcinoma or MEN2; pregnant, planning pregnancy, or breastfeeding; severe GI or end-stage organ disease.

The branded path. Start today.

The 3-minute medical screener is free. We'll ask about your insurance early so we can advise on the right path.

Start your assessment